A Compound Heterozygosis of Two Novel Mutations in vWF Exacerbates vWD in a Chinese Pedigree

被引:0
|
作者
Hu, Jiajia [1 ]
Yu, He [1 ]
Wang, Wuchao [2 ]
Li, Jinfang [1 ]
Xu, Qinzhu [1 ]
Rong, Jiang [1 ]
Lu, Songsong [1 ,3 ]
机构
[1] Peking Univ Peoples Hosp, Dept Clin Lab, Beijing, Peoples R China
[2] Peking Univ Peoples Hosp, Dept Emergency, Beijing, Peoples R China
[3] Peking Univ Peoples Hosp, Dept Clin Lab, 11 Xizhimen South St, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
vWF; vWD; genetic analysis; coagulation; compound heterozygous mutations; VON-WILLEBRAND-FACTOR; DISEASE; VARIANTS; BIOLOGY; BINDING; GENE;
D O I
10.7754/Clin.Lab.2023.230707
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: von Willebrand disease (vWD), caused by mutations in the von Willebrand factor (vWF) coding gene, is a disease characterized by abnormal coagulation activity and a severe tendency for hemorrhage. Therefore, identifying mutations in vWF is important for diagnosing congenital vWD. Methods: We studied a 23 -year -old male vWD patient and his parents. Clotting methods were used to determine activated partial thromboplastin time (aPTT), prothrombin time (PT), fibrinogen (FIB) levels, FVIII activity. Chromogenic substrate method was used to determine vWF antigen and activity. The platelet count was determined. Mutations were searched using whole-exome sequencing and certified by Sanger sequencing. Clinical data, including activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), fibrinogen levels, FX activity, FX antigen levels, and the platelet count were collected. A mixing study was performed to eliminate the presence of coagulation factor inhibitors and lupus anticoagulants. Mutations were screened by using whole-exome sequencing (WES) and were verified by using Sanger sequencing. Results: The proband showed severely decreased vWF antigen, vWF activity, and FVIII activity. RIPA (RISTOCETIN-induced platelet aggregation) was 0%. Data from WES showed that the proband carried compound heterozygous variants vWF: NM_000552.5 (c.3213C>A p.Cys1071Ter) and vWF: NM_000552.5 (c.6598+2T>C). The proband's mother carried variant vWF: NM_000552.5 (c.3213C>A p.Cys1071Ter) while the proband's father carried variant vWF: NM_000552.5 (c.6598+2T>C). All laboratory test indexes of the proband's parents, including vWF antigen, vWF activity, and FVIII activity, were within the normal ranges. Conclusions: We identified a compound heterozygosis with two novel mutations in vWF (c.3213C>A, c.6598+2T >C) in a family pedigree, and our results demonstrate that the compound heterozygous mutations probably exacerbate vWD.
引用
收藏
页码:372 / 377
页数:6
相关论文
共 50 条
  • [1] A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree
    Lu, Songsong
    Lin, Weicheng
    Ji, Huijuan
    Su, Ming
    Zhao, Xiaotao
    Wang, Chengbin
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 176 - 181
  • [2] A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree (vol 144, pg 176, 2021)
    Lu, Songsong
    Lin, Weicheng
    Ji, Huijuan
    Su, Ming
    Zhao, Xiaotao
    Wang, Chengbin
    Wang, Deqing
    ACTA HAEMATOLOGICA, 2021, 144 (04) : 470 - 470
  • [3] Novel compound heterozygous mutations in ABCA4 in a Chinese pedigree with Stargardt disease
    Zhang, Jianping
    Qi, Anhui
    Wang, Xi
    Pan, Hong
    Mo, Haiming
    Huang, Jiwei
    Li, Honghui
    Chen, Zhenwen
    Wei, Meirong
    Wang, Binbin
    MOLECULAR VISION, 2016, 22 : 1514 - 1521
  • [4] Molecular analysis of two novel mutations in a Chinese pedigree with hereditary FVII deficiency
    Xing, Z.
    Wang, X.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 473 - 473
  • [5] Identification of novel vwf gene mutations in the Turkish type 2 VWD patient population
    Berber, E.
    Oymak, Y.
    Baltaci, O. F.
    Diz-Kucukkaya, R.
    Zulfikar, B. O.
    Kavakli, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 742 - 743
  • [6] Molecular characterization of two novel mutations causing factor X deficiency in a Chinese pedigree
    Wang, WB
    Fu, QH
    Zhou, RF
    Wu, WM
    Ding, QL
    Hu, YQ
    Wang, XF
    Wang, HL
    Wang, ZY
    HAEMOPHILIA, 2005, 11 (01) : 31 - 37
  • [7] Genotyping of VWD patients in the netherlands: phenotype-genotype discrepancies and 27 novel VWF gene mutations
    Boender, J.
    Sanders, Y.
    van Heerde, W.
    Cnossen, M.
    van Gorkom, B. L.
    Fijnvandraat, K.
    Schoormans, S.
    Dors, N.
    van der Bom, J.
    Meijer, K.
    Mauser-Bunschoten, E.
    Eikenboom, J.
    Leebeek, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 101 - 101
  • [8] Hereditary coagulation factor VII deficiency caused by novel compound heterozygous mutations in a Chinese pedigree: A case report
    Cai, Ruimin
    Li, Yi
    Xu, Wei
    Gao, Xue
    Feng, Qiang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)
  • [9] Amyloidosis cutis dyschromica caused by compound heterozygous GPNMB mutations in a Chinese pedigree
    Zhong, Ci-Juan
    Li, Fang-Gu
    Li, Wen
    Fan, Yi-Ming
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2025, 100 (01) : 174 - 178
  • [10] Compound Heterozygosity for Two Novel SLC26A4 Mutations in a Large Iranian Pedigree with Pendred Syndrome
    Yazdanpanahi, Nasrin
    Tabatabaiefar, Mohammad Amin
    Farrokhi, Effat
    Abdian, Narges
    Bagheri, Nader
    Shahbazi, Shirin
    Noormohammadi, Zahra
    Chaleshtori, Morteza Hashennzadeh
    CLINICAL AND EXPERIMENTAL OTORHINOLARYNGOLOGY, 2013, 6 (04) : 201 - 208